Smile-Link Healthcare Global Bhd (XKLS:03023) ROE %: 0.49% (As of Dec. 2025) — 84% Below Median


What is Smile-Link Healthcare Global Bhd ROE %?

Smile-Link Healthcare Global Bhd XKLS:03023 ROE % is 0.49% as of Dec. 2025, which is 84% below its 10-year median of 3.09. The stock has 6 warning signs investors should review. Among 626 Healthcare Providers & Services companies, Smile-Link Healthcare Global Bhd ranks worse than 71.88% on this metric.

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Smile-Link Healthcare Global Bhd's annualized net income for the quarter that ended in Dec. 2025 was RM0.14 Mil. Smile-Link Healthcare Global Bhd's average Total Stockholders Equity over the quarter that ended in Dec. 2025 was RM29.33 Mil. Therefore, Smile-Link Healthcare Global Bhd's annualized ROE % for the quarter that ended in Dec. 2025 was 0.49%.

The historical rank and industry rank for Smile-Link Healthcare Global Bhd's ROE % or its related term are showing as below:

XKLS:03023' s ROE % Range Over the Past 10 Years
Min: -5.53   Med: 3.09   Max: 71.05
Current: -1.96

During the past 9 years, Smile-Link Healthcare Global Bhd's highest ROE % was 71.05%. The lowest was -5.53%. And the median was 3.09%.

XKLS:03023's ROE % is ranked worse than
71.88% of 626 companies
in the Healthcare Providers & Services industry
Industry Median: 5.805 vs XKLS:03023: -1.96

Smile-Link Healthcare Global Bhd  (XKLS:03023) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0.144/29.329
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(0.144 / 23.394)*(23.394 / 42.0665)*(42.0665 / 29.329)
=Net Margin %*Asset Turnover*Equity Multiplier
=0.62 %*0.5561*1.4343
=ROA %*Equity Multiplier
=0.34 %*1.4343
=0.49 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2025 )
=Net Income/Total Stockholders Equity
=0.144/29.329
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (0.144 / 0.454) * (0.454 / 0.958) * (0.958 / 23.394) * (23.394 / 42.0665) * (42.0665 / 29.329)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.3172 * 0.4739 * 4.1 % * 0.5561 * 1.4343
=0.49 %

Note: The net income data used here is two times the semi-annual (Dec. 2025) net income data. The Revenue data used here is two times the semi-annual (Dec. 2025) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.

Smile-Link Healthcare Global Bhd ROE % Related Terms

Smile-Link Healthcare Global Bhd ROE % Historical Data

* Premium members only.

The historical data trend for Smile-Link Healthcare Global Bhd's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Smile-Link Healthcare Global Bhd ROE % Chart

Smile-Link Healthcare Global Bhd Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Jun25
ROE %
Get a 7-Day Free Trial Premium Member Only 2.83 -5.53 3.09 0.27 -0.38

Smile-Link Healthcare Global Bhd Semi-Annual Data
Dec16 Dec17 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.88 -26.71 3.58 -4.39 0.49

XKLS:03023 vs HCA, THC, DVA: ROE % Comparison

For the Medical Care Facilities subindustry, Smile-Link Healthcare Global Bhd's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Smile-Link Healthcare Global Bhd ROE % vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Smile-Link Healthcare Global Bhd's ROE % distribution charts can be found below:

* The bar in red indicates where Smile-Link Healthcare Global Bhd's ROE % falls into.


Smile-Link Healthcare Global Bhd ROE % Calculation

Smile-Link Healthcare Global Bhd's annualized ROE % for the fiscal year that ended in Jun. 2025 is calculated as

ROE %=Net Income (A: Jun. 2025 )/( (Total Stockholders Equity (A: Dec. 2023 )+Total Stockholders Equity (A: Jun. 2025 ))/ count )
=-0.118/( (33.398+29.279)/ 2 )
=-0.118/31.3385
=-0.38 %

Smile-Link Healthcare Global Bhd's annualized ROE % for the quarter that ended in Dec. 2025 is calculated as

ROE %=Net Income (Q: Dec. 2025 )/( (Total Stockholders Equity (Q: Jun. 2025 )+Total Stockholders Equity (Q: Dec. 2025 ))/ count )
=0.144/( (29.279+29.379)/ 2 )
=0.144/29.329
=0.49 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is two times the semi-annual (Dec. 2025) net income data. ROE % is displayed in the 30-year financial page.

Frequently Asked Questions Learn more about ROE % →
What does a ROE % of 0.49% mean?
Smile-Link Healthcare Global Bhd (XKLS:03023) has a ROE % of 0.49% as of Dec. 2025. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Smile-Link Healthcare Global Bhd and its competitors. This is 84% below median its historical median of 3.09. According to the industry distribution chart, Smile-Link Healthcare Global Bhd ranks #450 out of 626 companies in the Healthcare Providers & Services industry, placing it in the top 71.9%.
Is Smile-Link Healthcare Global Bhd's ROE % too high?
Smile-Link Healthcare Global Bhd's current ROE % of 0.49% is 84% below median its 10-year median of 3.09. The Healthcare Providers & Services industry median ROE % is 5.81. Smile-Link Healthcare Global Bhd's value of 0.49% is 91.6% below this industry median. Based on the distribution chart, Smile-Link Healthcare Global Bhd ranks #450 out of 626 companies in the Healthcare Providers & Services industry, which is below the industry midpoint.
How does Smile-Link Healthcare Global Bhd's ROE % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Smile-Link Healthcare Global Bhd ranks #450 out of 626 companies for ROE %. This places Smile-Link Healthcare Global Bhd in the lower half of its industry. The industry median ROE % is 5.81. Smile-Link Healthcare Global Bhd's value of 0.49% is 91.6% below this benchmark. While the company's 10-year median is 3.09 vs. the industry median of 5.81, Smile-Link Healthcare Global Bhd has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % for a Healthcare Providers & Services company?
The median ROE % among Healthcare Providers & Services companies is 5.81, based on 626 companies in the industry. Companies in the top quartile (top 25%) have a ROE % significantly above this median, while those in the bottom quartile fall well below. However, ROE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Smile-Link Healthcare Global Bhd's current ROE % of 0.49% is 91.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % mean?
A high ROE % can signal that a stock is expensive relative to its fundamentals. Return on equity is the ratio of current-period net income to average two-period total equity. View historical data on Smile-Link Healthcare Global Bhd and its competitors. For the Healthcare Providers & Services industry, the median ROE % is 5.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Smile-Link Healthcare Global Bhd's current ROE % is 0.49%, which is 84% below median its own 10-year median of 3.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Smile-Link Healthcare Global Bhd stock overvalued right now?
Based on GuruFocus' analysis, Smile-Link Healthcare Global Bhd (XKLS:03023) is currently considered Fairly Valued. The stock's GF Value™ is RM0.10, compared to a current price of RM0.10 — trading right at its estimated fair value. The current ROE % is 0.49%, which is 84% below median its 10-year median of 3.09 and 91.6% below the Healthcare Providers & Services industry median of 5.81. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % calculated?
ROE % is calculated from a company's financial statements. For Smile-Link Healthcare Global Bhd (XKLS:03023), the current ROE % is 0.49% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Smile-Link Healthcare Global Bhd Business Description

Address Jalan Merah Caga, Lot PT 7221, Taman Sri Endah, Bandar Baru Sri Petaling, Kuala Lumpur, MYS, 57000
Smile-Link Healthcare Global Bhd through its subsidiaries, is engaged in providing dental healthcare services in Malaysia. Its reportable operating segments are; Provision of dental services which derives maximum revenue, Trading and distribution of dental and pharmaceutical products, Others, comprising dental labs and manufacturing of dental instruments, and Investment holding.